Found: 7
Select item for more details and to access through your institution.
Effectiveness and safety of secukinumab updosing in patients with moderate to severe plaque psoriasis: data from the PURE registry.
- Published in:
- Archives of Dermatological Research, 2024, v. 316, n. 7, p. 1, doi. 10.1007/s00403-024-03122-w
- By:
- Publication type:
- Article
Sustained Effectiveness of Secukinumab Across Different Body Regions in Patients with Moderate-to-Severe Plaque Psoriasis from the PURE Registry.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 2, p. 535, doi. 10.1007/s13555-022-00870-3
- By:
- Publication type:
- Article
Effectiveness and Safety of Secukinumab in Latin American Patients with Moderate to Severe Plaque Psoriasis: PURE Registry 12-Month Data.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 1, p. 269, doi. 10.1007/s13555-022-00849-0
- By:
- Publication type:
- Article
Correction: Intracrine signaling through lipid mediators and their cognate nuclear G-protein-coupled receptors: a paradigm based on PGE<sub>2</sub>, PAF, and LPA<sub>1</sub> receptors.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Rationale, objectives and design of PURE, a prospective registry of patients with moderate to severe chronic plaque psoriasis in Canada and Latin America.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The succinate receptor GPR91 in neurons has a major role in retinal angiogenesis.
- Published in:
- Nature Medicine, 2008, v. 14, n. 10, p. 1067, doi. 10.1038/nm.1873
- By:
- Publication type:
- Article
Intracrine signaling through lipid mediators and their cognate nuclear G-protein-coupled receptors: a paradigm based on PGE<sub>2</sub>, PAF, and LPA<sub>1</sub> receptors.
- Published in:
- Canadian Journal of Physiology & Pharmacology, 2006, v. 84, n. 3/4, p. 377, doi. 10.1139/Y05-147
- By:
- Publication type:
- Article